Skip to main content
Premium Trial:

Request an Annual Quote

Tobira Therapeutics Taps Pharsight's PKS Online to Support HIV Drug Development


Pharsight, a St. Louis, Mo.-based software firm, said this week that Tobira Therapeutics has selected PKS Online to support its HIV drug development efforts.

Tobira will use the software to analyze, manage, and report data for its HIV drug candidate cenicriviroc, an antagonist of both CCR5, a co-receptor that’s required for HIV infection, and CCR2, a co-receptor that is involved in a number of metabolic and cardiovascular diseases. The drug is currently in Phase 2 clinical development.

David Martin, Tobira's senior vice president of drug development and regulatory affairs, said that PKS Online "[eliminates] the need for deployment, validation, and management of an in-house system."

"With PKS Online, I have real-time visibility and streamlined access to time-critical analyses and study results, available on my desktop, to readily share with our management team, scientific advisors, and other key stakeholders," he said in a statement.

PKS Online is a software-as-a-service implementation of Pharsight Knowledgebase Server, an enterprise data management system for storing and tracking pharmacokinetic and pharmacodynamic data and analyses.

Among other features, the system lets users export studies in the Clinical Data Interchange Standards Consortium format for regulatory submission as well as simplify data-management tasks required to create multi-study analyses and prepare pharmacometric models.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more